SYGNIS Pharma AG Set to Build on 2008 Achievements to Create Further Growth in 2009

Heidelberg, January 14, 2009 – SYGNIS Pharma AG (Frankfurt: LIO; ISIN DE0005043509; Prime Standard) today provided an update on its preparations for the next trial with AX200 in acute stroke as well as highlighting the milestones achieved in 2008.